DRP004136
Evolution of drug-resistant hepatitis C virus clones during direct-acting antiviral therapy.
Hepatitis C virus (HCV) resistance-associated variants are associated with treatment failure in HCV-infected patients receiving direct-acting antivirals (DAAs). We evaluated the clonal origin and dynamics of resistance-associated variants in patients undergoing DAA therapy.